Table of Content

1. Introduction


2. Research Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Porter’s Five Forces

5.1 Bargaining Power of Buyer
5.2 Bargaining Power of Supplier
5.3 Threat of New Entrants
5.4 Rivalry among Existing Competitors
5.5 Threat of Substitute Products


6. SWOT Analysis

6.1 Strengths
6.2 Weaknesses
6.3 Opportunities
6.4 Threats


7. Population Analysis - Europe Breast Cancer Screening Market

7.1 Europe Breast Cancer Mammography Screening Population
7.2 Europe Breast Cancer MRI & Ultrasound Screening Population


8. Europe Breast Cancer Screening Market Analysis

8.1 Europe Breast Cancer Screening Market

8.1.1 Mammography Screening Market
8.1.2 MRI Screening Market
8.1.3 Ultrasound Screening Market


9. Population Share Analysis - Europe Breast Cancer Screening

9.1 Mammography Screening Population Share
9.2 MRI & Ultrasound Screening Population Share


10. Share Analysis - Europe Breast Cancer Screening Market

10.1 Europe Breast Cancer Screening
10.2 Mammography Screening
10.3 MRI Screening
10.4 Ultrasound Screening


11. United Kingdom

11.1 United Kingdom Breast Cancer Mammography Screening Population
11.2 United Kingdom Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
11.3 United Kingdom Breast Cancer Screening Market

11.3.1 Mammography Screening Market
11.3.2 Magnetic Resonance Imaging (MRI) Screening Market
11.3.3 Ultrasound Screening Market


12. France

12.1 France Breast Cancer Mammography Screening Population
12.2 France Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
12.3 France Breast Cancer Screening Market

12.3.1 Mammography Screening Market
12.3.2 Magnetic Resonance Imaging (MRI) Screening Market
12.3.3 Ultrasound Screening Market


13. Germany

13.1 Germany Breast Cancer Mammography Screening Population
13.2 Germany Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
13.3 Germany Breast Cancer Screening Market

13.3.1 Mammography Screening Market
13.3.2 Magnetic Resonance Imaging (MRI) Screening Market
13.3.3 Ultrasound Screening Market


14. Italy

14.1 Italy Breast Cancer Mammography Screening Population
14.2 Italy Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
14.3 Italy Breast Cancer Screening Market

14.3.1 Mammography Screening Market
14.3.2 Magnetic Resonance Imaging (MRI) Screening Market
14.3.3 Ultrasound Screening Market


15. Spain

15.1 Spain Breast Cancer Mammography Screening Population
15.2 Spain Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
15.3 Spain Breast Cancer Screening Market

15.3.1 Mammography Screening Market
15.3.2 Magnetic Resonance Imaging (MRI) Screening Market
15.3.3 Ultrasound Screening Market & Forecast


16. Switzerland

16.1 Switzerland Breast Cancer Mammography Screening Population
16.2 Switzerland Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
16.3 Switzerland Breast Cancer Screening Market

16.3.1 Mammography Screening Market
16.3.2 Magnetic Resonance Imaging (MRI) Screening Market
16.3.3 Ultrasound Screening Market


17. Norway

17.1 Norway Breast Cancer Mammography Screening Population
17.2 Norway Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
17.3 Norway Breast Cancer Screening Market

17.3.1 Mammography Screening Market
17.3.2 Magnetic Resonance Imaging (MRI) Screening Market
17.3.3 Ultrasound Screening Market


18. Netherlands

18.1 Netherlands Breast Cancer Mammography Screening Population
18.2 Netherlands Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
18.3 Netherlands Breast Cancer Screening Market

18.3.1 Mammography Screening Market
18.3.2 Magnetic Resonance Imaging (MRI) Screening Market
18.3.3 Ultrasound Screening Market


19. Company Analysis

19.1 AstraZeneca

19.1.1 Overview
19.1.2 Recent Development
19.1.3 Revenue

19.2 Novartis

19.2.1 Overview
19.2.2 Recent Development
19.2.3 Revenue

19.3 Sanofi

19.3.1 Overview
19.3.2 Recent Development
19.3.3 Revenue

19.4 Pfizer

19.4.1 Overview
19.4.2 Recent Development
19.4.3 Revenue

19.5 Bayer AG

19.5.1 Overview
19.5.2 Recent Development
19.5.3 Revenue

19.6 GlaxoSmithKline plc

19.6.1 Overview
19.6.2 Recent Development
19.6.3 Revenue



List of Figures

Figure-01: Europe – Breast Cancer Mammography Screening Population (Thousand), 2018 – 2022
Figure-02: Europe – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2023 – 2028
Figure-03: Europe – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2018 – 2022
Figure-04: Europe – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2023 – 2028
Figure-05: Europe – Breast Cancer Screening Market (Million US$), 2018 – 2022
Figure-06: Europe – Forecast for Breast Cancer Screening Market (Million US$), 2023 – 2028
Figure-07: Europe – Breast Cancer Mammography Screening Market (Million US$), 2018 – 2022
Figure-08: Europe – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 – 2028
Figure-09: Europe – Breast Cancer MRI Screening Market (Million US$), 2018 – 2022
Figure-10: Europe – Forecast for Breast Cancer MRI Screening Market (Million US$), 2023 – 2028
Figure-11: Europe – Breast Cancer Ultrasound Screening Market (Million US$), 2018 – 2022
Figure-12: Europe – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 – 2028
Figure-13: United Kingdom – Breast Cancer Mammography Screening Population (Thousand), 2018 – 2022
Figure-14: United Kingdom – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2023 – 2028
Figure-15: United Kingdom – Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2018 – 2022
Figure-16: United Kingdom – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2023 – 2028
Figure-17: United Kingdom – Breast Cancer Mammography Screening Market (Million US$), 2018 – 2022
Figure-18: United Kingdom – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 – 2028
Figure-19: United Kingdom – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 – 2022
Figure-20: United Kingdom – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 – 2028
Figure-21: United Kingdom – Breast Cancer Ultrasound Screening Market (Million US$), 2018 – 2022
Figure-22: United Kingdom – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 – 2028
Figure-23: France – Breast Cancer Mammography Screening Population (Thousand), 2018 – 2022
Figure-24: France – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2023 – 2028
Figure-25: France – Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2018 – 2022
Figure-26: France – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2023 – 2028
Figure-27: France – Breast Cancer Mammography Screening Market (Million US$), 2018 – 2022
Figure-28: France – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 – 2028
Figure-29: France – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 – 2022
Figure-30: France – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 – 2028
Figure-31: France – Breast Cancer Ultrasound Screening Market (Million US$), 2018 – 2022
Figure-32: France – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 – 2028
Figure-33: Germany – Breast Cancer Mammography Screening Population (Thousand), 2018 – 2022
Figure-34: Germany – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2023 – 2028
Figure-35: Germany – Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2018 – 2022
Figure-36: Germany – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2023 – 2028
Figure-37: Germany – Breast Cancer Mammography Screening Market (Million US$), 2018 – 2022
Figure-38: Germany – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 – 2028
Figure-39: Germany – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 – 2022
Figure-40: Germany – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 – 2028
Figure-41: Germany – Breast Cancer Ultrasound Screening Market (Million US$), 2018 – 2022
Figure-42: Germany – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 – 2028
Figure-43: Italy – Breast Cancer Mammography Screening Population (Thousand), 2018 – 2022
Figure-44: Italy – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2023 – 2028
Figure-45: Italy – Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2018 – 2022
Figure-46: Italy – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2023 – 2028
Figure-47: Italy – Breast Cancer Mammography Screening Market (Million US$), 2018 – 2022
Figure-48: Italy – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 – 2028
Figure-49: Italy – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 – 2022
Figure-50: Italy – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 – 2028
Figure-51: Italy – Breast Cancer Ultrasound Screening Market (Million US$), 2018 – 2022
Figure-52: Italy – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 – 2028
Figure-53: Spain – Breast Cancer Mammography Screening Population (Thousand), 2018 – 2022
Figure-54: Spain – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2023 – 2028
Figure-55: Spain – Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2018 – 2022
Figure-56: Spain – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2023 – 2028
Figure-57: Spain – Breast Cancer Mammography Screening Market (Million US$), 2018 – 2022
Figure-58: Spain – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 – 2028
Figure-59: Spain – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 – 2022
Figure-60: Spain – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 – 2028
Figure-61: Spain – Breast Cancer Ultrasound Screening Market (Million US$), 2018 – 2022
Figure-62: Spain – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 – 2028
Figure-63: Switzerland – Breast Cancer Mammography Screening Population (Thousand), 2018 – 2022
Figure-64: Switzerland – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2023 – 2028
Figure-65: Switzerland – Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2018 – 2022
Figure-66: Switzerland – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2023 – 2028
Figure-67: Switzerland – Breast Cancer Mammography Screening Market (Million US$), 2018 – 2022
Figure-68: Switzerland – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 – 2028
Figure-69: Switzerland – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 – 2022
Figure-70: Switzerland – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 – 2028
Figure-71: Switzerland – Breast Cancer Ultrasound Screening Market (Million US$), 2018 – 2022
Figure-72: Switzerland – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 – 2028
Figure-73: Norway – Breast Cancer Mammography Screening Population (Thousand), 2018 – 2022
Figure-74: Norway – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2023 – 2028
Figure-75: Norway – Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2018 – 2022
Figure-76: Norway – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2023 – 2028
Figure-77: Norway – Breast Cancer Mammography Screening Market (Million US$), 2018 – 2022
Figure-78: Norway – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 – 2028
Figure-79: Norway – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 – 2022
Figure-80: Norway – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 – 2028
Figure-81: Norway – Breast Cancer Ultrasound Screening Market (Million US$), 2018 – 2022
Figure-82: Norway – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 – 2028
Figure-83: Netherlands – Breast Cancer Mammography Screening Population (Thousand), 2018 – 2022
Figure-84: Netherlands – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2023 – 2028
Figure-85: Netherlands – Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2018 – 2022
Figure-86: Netherlands – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2023 – 2028
Figure-87: Netherlands – Breast Cancer Mammography Screening Market (Million US$), 2018 – 2022
Figure-88: Netherlands – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 – 2028
Figure-89: Netherlands – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 – 2022
Figure-90: Netherlands – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 – 2028
Figure-91: Netherlands – Breast Cancer Ultrasound Screening Market (Million US$), 2018 – 2022
Figure-92: Netherlands – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 – 2028
Figure-93: AstraZeneca – Global Revenue (Billion US$), 2018 – 2022
Figure-94: AstraZeneca – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-95: Novartis – Global Revenue (Billion US$), 2018 – 2022
Figure-96: Novartis – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-97: Sanofi – Global Revenue (Billion US$), 2018 – 2022
Figure-98: Sanofi – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-99: Pfizer – Global Revenue (Billion US$), 2018 – 2022
Figure-100: Pfizer – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-101: Bayer AG – Global Revenue (Billion US$), 2018 – 2022
Figure-102: Bayer AG – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-103: GlaxoSmithKline plc – Global Revenue (Billion US$), 2018 – 2022
Figure-104: GlaxoSmithKline plc – Forecast for Global Revenue (Billion US$), 2023 – 2028

List of Tables

Table-01: Europe – Mammography Screening Population Share by Country (Percent), 2018 – 2022
Table-02: Europe – Forecast for Mammography Screening Population Share by Country (Percent), 2023 – 2028
Table-03: Europe – MRI & Ultrasound Screening Population Share by Country (Percent), 2018 – 2022
Table-04: Europe – Forecast for MRI & Ultrasound Screening Population Share by Country (Percent), 2023 – 2028
Table-05: Europe – Breast Cancer Screening Market Share by Country (Percent), 2018 – 2022
Table-06: Europe – Forecast for Breast Cancer Screening Market Share by Country (Percent), 2023 – 2028
Table-07: Europe – Mammography Screening Market Share by Country (Percent), 2018 – 2022
Table-08: Europe – Forecast for Mammography Screening Market Share by Country (Percent), 2023 – 2028
Table-09: Europe – MRI Screening Market Share by Country (Percent), 2018 – 2022
Table-10: Europe – Forecast for MRI Screening Market Share by Country (Percent), 2023 – 2028
Table-11: Europe – Ultrasound Screening Market Share by Country (Percent), 2018 – 2022
Table-12: Europe – Forecast for Ultrasound Screening Market Share by Country (Percent), 2023 – 2028